Used as a reference standard in pharmaceutical analytical testing. Employed in impurity profiling and characterization studies. Utilized in HPLC UPLC and LC-MS method development and validation. Applied in stability-indicating studies to evaluate degradation behavior. Supports compliance with European Pharmacopoeia specifications and regulatory requirements.

The primary purpose of Doxylamine EP Impurity C is to facilitate the identification quantification and control of related impurities in doxylamine drug substances and finished products ensuring their quality safety efficacy and regulatory compliance

Doxylamine EP Impurity C is a specified related substance described in the European Pharmacopoeia (EP) for the quality control of Doxylamine. It is a known impurity that may arise during the synthesis processing storage or degradation of doxylamine and is monitored as part of pharmaceutical quality assurance programs.